|
L-base
|
716-61-0
|
Chloramphenicol intermediate
|
|
2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate
|
160969-03-9
|
Silodosin intermediate
|
|
(1R)-(S)-Pinanediol 1-Ammonium trifluoroacetate-3-Methylbutane-1-BORONATE
|
179324-87-9
|
Bortezomib intermediate
|
|
Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate
|
163521-20-8
|
Vilazodone intermediate
|
|
3-(4-Chlorbutyl)-1H-indol-5-carbonitrile
|
143612-79-7
|
Vilazodone intermediate
|
|
5-(1-piperazinyl)-2-benzofurancarboxylic acid ethyl ester hydrochloride
|
765935-67-9
|
Vilazodone intermediate
|
|
3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl]methyl]-1-oxo-5-[(trimethylsily)-oxy]pentyl]-4-phenyl-(4S)-2-oxazolidinone
|
272778-12-8
|
Ezetimibe intermediate
|
|
N-[(S)-(2,3,4,5,6-Pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-methylethyl ester
|
1334513-02-8
|
Sofobusvir intermediate
|
|
2'-deoxy-2'-fluoro-2'-C-methyluridine
|
863329-66-2
|
Sofobusvir intermediate
|
|
6,7-dihydro-6-mercapto-5h-pyrazolo[1,2-a][1,2,4]triazol-4-ium chloride
|
153851-71-9
|
Biapenem sidechain
|
|
Boc-3-Hydroxy-1-adamantyl-D-glycine
|
361442-00-4
|
Saxagliptin intermediate
|
|
1-(4,5-Dihydro-2-thiazolyl)-3-azetidinethiol hydrochloride
|
179337-57-6
|
Tebipenem sidechain
|
|
alpha-Bromo-o-tolunitrile
|
22115-41-9
|
Alogliptin intermediate
|
|
6-Chloro-3-methyluracil
|
4318-56-3
|
Alogliptin intermediate, Trelagliptin intermediate
|
|
Benzonitrile, 2-[(6-chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]-
|
865758-96-9
|
Alogliptin intermediate, Trelagliptin intermediate
|
|
(5-Bromo-2-chlorophenyl)(4-fluorophenyl)methanone
|
915095-85-1
|
Empagliflozin intermediate
|
|
Quinazoline, 2-(chloromethyl)-4-methyl-
|
109113-72-6
|
Linagliptin intermediate
|
|
8-bromo-7-but-2-yn-1-yl-3-methyl-3,7-dihydro-1H-purine-2,6-dione
|
666816-98-4
|
Linagliptin intermediate
|
|
1-[(4-methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine
|
853029-57-9
|
Linagliptin intermediate
|
|
3-Methylxanthine
|
1076-22-8
|
Linagliptin intermediate
|
|
3-Methyl-8-bromoxanthine
|
93703-24-3
|
Linagliptin intermediate
|
|
(R)-3-(Boc-Amino)piperidine
|
309956-78-3
|
Linagliptin intermediate
|
|
(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid
|
1012341-50-2
|
LCZ696 intermediate
|
|
(R,E)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid
|
1012341-48-8
|
LCZ696 intermediate
|
|
(Carbethoxyethylidene)triphenylphosphorane
|
5717-37-3
|
LCZ696 intermediate
|
|
AHU377 Calcium salt
|
1369773-39-6
|
LCZ696 intermediate
|
|
(R)-tert-butyl (1-([1,1'-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate
|
1426129-50-1
|
LCZ696 intermediate
|
|
Phosphonic acid,[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, monophenylester
|
379270-35-6
|
Tenofovir Disoproxil intermediate
|
|
((3aR,4R,6R,6aR)-6-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate
|
2346620-55-9
|
Molnupiravir intermediate
|
|
2,4-dimethyl-5-Pyrimidinol
|
412003-95-3
|
Lemborexant intermediate
|
|
Cefazedone
|
56187-47-4
|
Cefazedone Sodium intermediate
|
|
Cefteram
|
82547-58-8
|
Cefteram pivoxil intermediate
|
|
7-TMCA
|
24209-38-9
|
"Cefmenoxime intermediate,
Cefpiramide intermediate, Cefoperazone intermediate"
|
|
DCPA
|
56187-37-2
|
Cefazedone sidechain
|
|
7-TDA
|
30246-33-4
|
Cefazedone intermediate, Cephazolin intermediate
|
|
4-Pyridinol
|
626-64-2
|
Torasemide intermediate
|
|
2-Dimethylaminoethyl chloride hydrochloride
|
4584-46-7
|
Pharmaceutical intermediate
|
|
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene
|
898566-17-1
|
Canagliflozin intermediate
|
|
3-(4-phenoxyphenyl)-1-(3-piperidyl)pyrazolo[3,4-d]pyrimidin-4-amine
|
1022150-12-4
|
Ibrutinib inttermediate
|
|
2-(Methoxy(4-phenoxyphenyl)Methylene)Malononitrile
|
330792-69-3
|
Ibrutinib inttermediate
|
|
3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
330786-24-8
|
Ibrutinib inttermediate
|
|
(S)-1-(2,6-Dichloro-3-fluorophenyl)ethanol
|
877397-65-4
|
Crizotinib intermediate
|
|
(S)-1-(5-fluoro-2-iodophenyl)ethan-1-ol
|
1454847-96-1
|
Lorlatinib intermediate
|
|
(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol
|
127852-28-2
|
Fosaprepitant Dimeglumine intermediate
|
|
(S)-3-Methyl-1-(2-(1-piperidinyl)phenyl)butylamine, N-acetyl-glutarate
|
219921-94-5
|
Repaglinide intermediate
|
|
4-Ethoxycaybonyl-3-ethoxyphenyiaceticacid
|
99469-99-5
|
Repaglinide intermediate
|
|
5-Chloro-2-((R)-5-methyl-[1,4]diazepan-1-yl)benzooxazole hydrochloride
|
1266664-66-7
|
Suvorexant intermediate
|
|
(S)-(+)-Glycidyl Phthalimide
|
161596-47-0
|
Rivaroxaban intermediate
|
|
4-(4-aminophenyl)morpholin-3-one
|
438056-69-0
|
Rivaroxaban intermediate
|
|
5-Chloro-2-thiophenecarboxylic acid
|
24065-33-6
|
Rivaroxaban intermediate
|
|
1-(2-Fluorobenzyl)-1H-Pyrazolo[3,4-B]Pyridine-3-Carboximidamide Hydrochloride
|
256499-19-1
|
Riociguat intermediate
|
|
3-Acetamidophthalic anhydride
|
6296-53-3
|
Apremilast inttermediate
|
|
(S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine
|
608141-42-0
|
Apremilast inttermediate
|
|
(S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethylamine N-acetyl-L-leucine salt
|
608141-43-1
|
Apremilast inttermediate
|
|
2-isopropoxy-5-methyl-4-(piperidin-4-yl) aniline dihydrochloride monohydrate
|
1802250-63-0
|
Ceritinib intermediate
|
|
2,5-dichloro-N-(2-(isopropylsulfonyl)phenyl)pyrimidin-4-amine
|
761440-16-8
|
Ceritinib intermediate
|
|
1-chloro-5-isopropoxy-2-methyl-4-nitrobenzene
|
1032903-50-6
|
Ceritinib intermediate
|
|
1-Bromo-5-isopropoxy-2-Methyl-4-nitrobenzene
|
1202858-68-1
|
Ceritinib intermediate
|
|
2-(Isopropylsulphonyl)aniline
|
76697-50-2
|
Ceritinib intermediate
|
|
tert-butyl 4-(4-aMino-5-isopropoxy-2-Methylphenyl)piperidine-1-carboxylate
|
1032903-63-1
|
Ceritinib intermediate
|
|
4-(5-isopropoxy-2-methyl-4-nitrophenyl)pyridine
|
1032903-62-0
|
Ceritinib intermediate
|
|
4-Amino-3-chlorophenol hydrochloride
|
52671-64-4
|
Lenvatinib intermediate
|
|
Methyl 7-Methoxy-4-oxo-1,4-dihydroquinoline-6-carboxylate
|
205448-65-3
|
Lenvatinib intermediate
|
|
N-(2-chloro-4-hydroxyphenyl)-N'-cyclopropyl-Urea
|
796848-79-8
|
Lenvatinib intermediate
|
|
methyl 4-chloro-7-methoxyquinoline-6-carboxylate
|
205448-66-4
|
Lenvatinib intermediate
|
|
Methyl oxindole-6-carboxylate
|
14192-26-8
|
Nintedanib intermediate
|
|
N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide
|
262368-30-9
|
Nintedanib intermediate
|
|
N-(2-chloropyrimidin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine
|
444731-75-3
|
Pazopanib intermediate
|
|
2,3-Dimethyl-6-Amino-2H-Indazole
|
444731-72-0
|
Pazopanib intermediate
|
|
2,3-dimethylindazol-6-amine hydrochloride
|
635702-60-2
|
Pazopanib intermediate
|
|
6-Hydroxy-7-methoxy-3,4-dihydroquinazolin-4-one
|
179688-52-9
|
Gefitinib intermediate
|
|
3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate
|
179688-53-0
|
Gefitinib intermediate
|
|
7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one
|
199327-61-2
|
Gefitinib intermediate
|
|
4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-ol
|
184475-71-6
|
Gefitinib intermediate
|
|
4-(3-Chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl acetate
|
788136-89-0
|
Gefitinib intermediate
|
|
6,7-Bis(2-methoxyethoxy)quinazolin-4-(3H)-one
|
179688-29-0
|
Erlotinib intermediate
|
|
4,5-bis(2-methoxyethoxy)-2-nitrobenzonitrile
|
236750-65-5
|
Erlotinib intermediate
|
|
2-Amino-4,5-bis(2-methoxyethoxy)benzonitrile
|
950596-58-4
|
Erlotinib intermediate
|
|
(E)-N-(2-Chloro-6-methylphenyl)-3-ethoxy acrylamide
|
863127-76-8
|
Dasatinib intermediate
|
|
2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide
|
302964-24-5
|
Dasatinib intermediate
|
|
N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide
|
302964-08-5
|
Dasatinib intermediate
|
|
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid
|
641569-94-0
|
Nilotinib intermediate
|
|
3-[(Aminoiminomethyl)amino]-4-methylbenzoic acid ethyl ester mononitrate
|
641569-96-2
|
Nilotinib intermediate
|
|
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline
|
641571-11-1
|
Nilotinib intermediate
|
|
4-(3-fluorobenzyloxy)-3-chlorobenzenamine
|
202197-26-0
|
Lapatinib intermediate
|
|
3-Chloro-4-(3-fluorobenzyloxy)nitrobenzene
|
443882-99-3
|
Lapatinib intermediate
|
|
N-[3-Chloro-4-(3-fluorobenzyloxy)-phenyl]-6-iodoquinazolin-4-amine
|
231278-20-9
|
Lapatinib intermediate
|
|
6-iodoquinazolin-4-ol
|
16064-08-7
|
Lapatinib intermediate
|
|
Ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate
|
2199-59-9
|
Sunitinib intermediate
|
|
5-Formyl-2,4-Dimethyl-1H-Pyrrole-3-Carboxylic Acid
|
253870-02-9
|
Sunitinib intermediate
|
|
4-(4-Aminophenoxy)-N-methylpicolinamide
|
284462-37-9
|
Sorafenib intermediate
|
|
4-Chloro-N-Methylpyridine-2-Carboxamide
|
220000-87-3
|
Sorafenib intermediate
|
|
n4-(3-chloro-4-fluorophenyl)-7-methoxyquinazoline-4,6-diamine
|
179552-75-1
|
Dacomitinib intermediate
|
|
4-(1H-Pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl-7H-pyrrolo[2,3-d]pyrimidine
|
941685-27-4
|
Baricitinib intermediate
|
|
(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-
4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile
|
1187594-13-3
|
Baricitinib intermediate
|
|
Boc-Cefcapene.DIPA
|
153012-37-4
|
Cefcapene intermediate
|
|
Parent nucleus of Ceftazidime
|
96752-43-1
|
Ceftazidime intermediate
|
|
Ticarcillin intermediate(3-ATMA)
|
61857-83-8
|
Ticarcillin intermediate
|
|
Alpha-Sulfophenylacetic acid
|
41360-32-1
|
"Sulbenicillin intermediate;
Cefsulodin inttemediate"
|
|
2-Hydroxy-1-naphthaldehyde
|
708-06-5
|
Nafcillin intermediate
|
|
2-Ethoxy-1-naphthoic acid
|
2224-00-2
|
Nafcillin intermediate
|
